Good afternoon, ladies and gentlemen. I want to welcome you to the health committee. I am Joy Smith, the chair of the committee. We're very pleased to have you here today.
Pursuant to Standing Order 108(2), this is a briefing on the health implications of the supply of radioisotopes.
Today we're going to ask each organization, in turn, to make a presentation. Each person will have a five-minute presentation.
We have before us today Dr. Jean-Luc Urbain, president of the Canadian Association of Nuclear Medicine. Welcome, Dr. Urbain.
We have Dr. Anne Doig, president of the Canadian Medical Association. Thank you, Dr. Doig .
We have, from the Ontario Association of Nuclear Medicine, Dr. Christopher O'Brien. Welcome, Dr. O'Brien.
From the New Brunswick Cancer Network, we have Dr. Eshwar Kumar. Welcome to you. I welcomed you a little earlier, but I'll welcome you again, Doctor.
And from the European Association of Nuclear Medicine, we have Patrick Bourguet, who is president-elect of the European Association of Nuclear Medicine.
We also have Dr. Alexander McEwan, who has joined us. I looked up and there you were, Dr. McEwan. Thank you for being here. Dr. McEwan is a special adviser on medical isotopes to the Minister of Health.
We welcome you here. As I said, you'll each have a chance. We're going to start with Dr. Anne Doig from the Canadian Medical Association, who will have a five-minute presentation. Following all of your presentations, we'll then go into questions and answers.
Dr. Doig, welcome.